{"id":55867,"date":"2024-02-07T05:43:51","date_gmt":"2024-02-07T05:43:51","guid":{"rendered":"https:\/\/medsname.com\/alphagan-p-drop\/"},"modified":"2026-04-30T10:24:43","modified_gmt":"2026-04-30T10:24:43","slug":"alphagan-p-drop","status":"publish","type":"product","link":"https:\/\/medsbase.com\/el\/alphagan-p-drop\/","title":{"rendered":"Alphagan P Drop"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fffbe6;border-left:4px solid #f5a623;padding:14px 18px;margin:14px 0 22px;border-radius:6px;font-size:15px;line-height:1.55;\">\n<h3 style=\"margin:0 0 6px;font-size:17px;color:#8a6d3b;\">\u26a1 Quick Answer \u2014 What is Alphagan P Drop?<\/h3>\n<p style=\"margin:0;\">Alphagan P Drop is brimonidine 0.15%, an alpha-2 adrenergic agonist eye drop that lowers eye pressure ~20% by reducing aqueous production AND increasing uveoscleral outflow. Three times daily dosing. Caution in children \u2014 avoid in age &lt; 2 years (apnoea risk).<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f6f7fb;border:1px solid #e3e5ee;border-radius:8px;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.55;\"><strong style=\"color:#1f3661;\">\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03b1\u03b3\u03bf\u03c1\u03ac\u03c3\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase;<\/strong> \u03a0\u03c1\u03bf\u03ad\u03c1\u03c7\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ad\u03bd\u03b1\u03bd \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ae \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf \u03b1\u03c0\u03cc \u03c4\u03bf\u03bd WHO-GMP \u00b7 \u0394\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u00b7 \u03a0\u03b1\u03b3\u03ba\u03cc\u03c3\u03bc\u03b9\u03b1 \u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae \u00b7 <a href=\"\/el\/reviews\/\" rel=\"noopener\">1,400+ \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 \u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd <a href=\"https:\/\/medsbase.com\/el\/medsbase-re-shipment-assurance-policy\/\"><strong>\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n<h3>\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n<p>Alphagan P Drop is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our <a href=\"\/el\/medsbase-re-shipment-assurance-policy\/\" rel=\"noopener\">\u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/a> \u2014 \u03b5\u03ac\u03bd \u03b4\u03b5\u03bd \u03ad\u03c7\u03b5\u03b9 \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03bc\u03b5\u03c4\u03ac \u03b1\u03c0\u03cc 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03b5\u03c2 \u03b7\u03bc\u03ad\u03c1\u03b5\u03c2, \u03c4\u03bf \u03be\u03b1\u03bd\u03b1\u03c3\u03c4\u03ad\u03bb\u03bd\u03bf\u03c5\u03bc\u03b5 \u03c7\u03c9\u03c1\u03af\u03c2 \u03b5\u03c0\u03b9\u03c0\u03bb\u03ad\u03bf\u03bd \u03ba\u03cc\u03c3\u03c4\u03bf\u03c2. \u03a5\u03c0\u03bf\u03c3\u03c4\u03b7\u03c1\u03af\u03b6\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c0\u03ac\u03bd\u03c9 \u03b1\u03c0\u03cc 1,400 \u03b5\u03c0\u03b1\u03bb\u03b7\u03b8\u03b5\u03c5\u03bc\u03ad\u03bd\u03b5\u03c2 \u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ad\u03c2 \u03c0\u03b5\u03bb\u03b1\u03c4\u03ce\u03bd.<\/p>\n<h2>What is Alphagan P Drop?<\/h2>\n<p>Alphagan P Drop is manufactured by Allergan and contains brimonidine tartrate 0.15% as a sterile ophthalmic solution. Brimonidine is a highly selective alpha-2 adrenergic agonist used to lower IOP in open-angle glaucoma and ocular hypertension. It has a unique dual mechanism \u2014 reducing aqueous humour production AND increasing uveoscleral outflow \u2014 and is one of the few glaucoma drops with a possible neuroprotective effect on retinal ganglion cells suggested by laboratory and small-cohort clinical evidence.<\/p>\n<h2>\u03a0\u03ce\u03c2 \u039b\u03b5\u03b9\u03c4\u03bf\u03c5\u03c1\u03b3\u03b5\u03af<\/h2>\n<p>Brimonidine activates alpha-2 receptors on the ciliary body, decreasing cAMP and reducing aqueous production. It also increases uveoscleral outflow. Average IOP reduction is 18\u201322%. The 0.15% formulation (Alphagan P) uses a Purite preservative system that breaks down in the tear film into water, oxygen, and chloride ions, making it gentler than benzalkonium chloride for long-term use.<\/p>\n<h2>\u0395\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2 &amp; \u03a7\u03bf\u03c1\u03ae\u03b3\u03b7\u03c3\u03b7<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">\u0395\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2<\/th>\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">\u0394\u03cc\u03c3\u03b7<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Open-angle glaucoma \/ ocular hypertension<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">1 drop in affected eye(s) three times daily (every 8 hours)<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">\u03a3\u03c5\u03bc\u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03b1\u03c4\u03b9\u03ba\u03ae \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Twice daily<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Post-laser (LPI, SLT) IOP spike prophylaxis<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">1 drop pre-procedure and 1 drop post-procedure<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:4px;font-size:14px;line-height:1.55;\"><strong style=\"color:#a94442;\">Paediatric apnoea \u2014 avoid in children &lt; 2 years.<\/strong> Brimonidine readily crosses the blood-brain barrier. In children younger than 2, even ophthalmic brimonidine has caused life-threatening CNS depression with apnoea, bradycardia, and hypotension. Avoid in age &lt; 2; use with extreme caution in age 2\u20136 years (Alphagan P 0.1% formulation only, with parental supervision and observation).<\/div>\n<h2>\u03a0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2<\/h2>\n<p><strong>Local (10\u201320%):<\/strong> conjunctival hyperaemia, allergic conjunctivitis (typically appears at 6\u201318 months \u2014 characteristic late onset), follicular conjunctivitis, eye pruritus, foreign body sensation, blurred vision.<\/p>\n<p><strong>\u03a3\u03c5\u03c3\u03c4\u03b7\u03bc\u03b9\u03ba\u03ac:<\/strong> dry mouth, fatigue, drowsiness, headache, hypotension. Children (especially under 6) can develop somnolence and bradycardia.<\/p>\n<h2>\u0395\u03b9\u03b4\u03bf\u03c0\u03bf\u03b9\u03ae\u03c3\u03b5\u03b9\u03c2 &amp; \u0391\u03bd\u03c4\u03b5\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2<\/h2>\n<ul>\n<li><strong>Children &lt; 2 years<\/strong> \u2014 absolute contraindication (apnoea risk)<\/li>\n<li>Children 2\u20136 years \u2014 use only with caution and supervision<\/li>\n<li>Concurrent MAO inhibitors \u2014 relative contraindication, additive sedation<\/li>\n<li>\u03a3\u03bf\u03b2\u03b1\u03c1\u03ae \u03ba\u03b1\u03c1\u03b4\u03b9\u03b1\u03b3\u03b3\u03b5\u03b9\u03b1\u03ba\u03ae \u03bd\u03cc\u03c3\u03bf\u03c2, \u03bf\u03c1\u03b8\u03bf\u03c3\u03c4\u03b1\u03c4\u03b9\u03ba\u03ae \u03c5\u03c0\u03cc\u03c4\u03b1\u03c3\u03b7<\/li>\n<li>Concurrent CNS depressants (alcohol, sedatives, opioids) \u2014 additive sedation<\/li>\n<li>\u0395\u03b3\u03ba\u03c5\u03bc\u03bf\u03c3\u03cd\u03bd\u03b7\/\u03b8\u03b7\u03bb\u03b1\u03c3\u03bc\u03cc\u03c2 \u2014 \u03c3\u03c5\u03b6\u03b7\u03c4\u03ae\u03c3\u03c4\u03b5 \u03bc\u03b5 \u03b5\u03b9\u03b4\u03b9\u03ba\u03cc<\/li>\n<\/ul>\n<h2>\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7<\/h2>\n<p>\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7 \u03c3\u03b5 \u03b8\u03b5\u03c1\u03bc\u03bf\u03ba\u03c1\u03b1\u03c3\u03af\u03b1 15\u201325\u00b0C \u03c0\u03c1\u03bf\u03c3\u03c4\u03b1\u03c4\u03b5\u03c5\u03bc\u03ad\u03bd\u03bf \u03b1\u03c0\u03cc \u03c4\u03bf \u03c6\u03c9\u03c2. \u0391\u03c0\u03cc\u03c1\u03c1\u03b9\u03c8\u03b7 28 \u03b7\u03bc\u03ad\u03c1\u03b5\u03c2 \u03bc\u03b5\u03c4\u03ac \u03c4\u03b7\u03bd \u03c0\u03c1\u03ce\u03c4\u03b7 \u03ac\u03bd\u03bf\u03b9\u03be\u03b7.<\/p>\n<h2 id=\"faqs\">\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n<h3>Why does Alphagan P Drop cause an allergic reaction late?<\/h3>\n<p>Brimonidine is one of the few glaucoma drops with classic late-onset allergic conjunctivitis \u2014 typically appearing 6\u201318 months into therapy. If your eyes start to feel itchy and red months after a smooth start, this is the likely cause. Stop the drop and discuss alternatives.<\/p>\n<h3>Is Alphagan P Drop neuroprotective?<\/h3>\n<p>Some preclinical and small clinical studies suggest brimonidine may protect retinal ganglion cells beyond the IOP-lowering effect. The Low-Pressure Glaucoma Treatment Study (LoGTS) showed less visual-field progression on brimonidine vs timolol despite equivalent IOP control. The evidence is suggestive rather than definitive.<\/p>\n<h3>Why three times a day?<\/h3>\n<p>Brimonidine has an 8-hour duration of action. Three-times-daily dosing maintains 24-hour IOP control as monotherapy. As an add-on it can usually be twice daily.<\/p>\n<h3>Can I use Alphagan P Drop with my child?<\/h3>\n<p>If your child is under 2 years old, do not use Alphagan P Drop \u2014 it can cause life-threatening apnoea. For children 2\u20136 years, use only under specialist supervision. Children over 6 are generally treated like adults but with closer monitoring for somnolence.<\/p>\n<h3>What is Purite preservative?<\/h3>\n<p>An oxidising preservative that breaks down on contact with the tear film into water, oxygen, and chloride ions. Gentler than benzalkonium chloride for long-term daily use.<\/p>\n<h3>Why does Alphagan P Drop make me feel tired?<\/h3>\n<p>Brimonidine crosses the blood-brain barrier and activates central alpha-2 receptors (similar to clonidine), causing sedation, dry mouth, and mild hypotension. Use punctal occlusion to reduce systemic absorption.<\/p>\n<h3>Can I combine Alphagan P Drop with other glaucoma drops?<\/h3>\n<p>Yes \u2014 additive with prostaglandins, beta-blockers, and CAIs. Wait 5 minutes between bottles. Fixed combinations such as brimonidine+timolol exist.<\/p>\n<h3>What if I take MAO inhibitors?<\/h3>\n<p>Avoid the combination \u2014 additive sedation and hypotension are possible. Discuss with your prescriber.<\/p>\n<h3>Can I drive after using Alphagan P Drop?<\/h3>\n<p>Brimonidine can cause drowsiness, especially when starting or in heat. Wait until you know how it affects you before driving long distances.<\/p>\n<h3>\u03a4\u03b9 \u03b3\u03af\u03bd\u03b5\u03c4\u03b1\u03b9 \u03b1\u03bd \u03c7\u03ac\u03c3\u03c9 \u03bc\u03b9\u03b1 \u03b4\u03cc\u03c3\u03b7;<\/h3>\n<p>Take it as soon as you remember unless the next scheduled dose is close. Do not double up.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3>\u0386\u03bb\u03bb\u03b1 \u03a6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03b7 \u03a6\u03c1\u03bf\u03bd\u03c4\u03af\u03b4\u03b1 \u03c4\u03c9\u03bd \u039c\u03b1\u03c4\u03b9\u03ce\u03bd<\/h3>\n<p>\u039f\u03b9 \u03c0\u03b5\u03bb\u03ac\u03c4\u03b5\u03c2 \u03c0\u03bf\u03c5 \u03b2\u03bb\u03ad\u03c0\u03bf\u03c5\u03bd \u03b1\u03c5\u03c4\u03cc \u03c4\u03bf \u03c0\u03c1\u03bf\u03ca\u03cc\u03bd \u03b5\u03be\u03b5\u03c4\u03ac\u03b6\u03bf\u03c5\u03bd \u03b5\u03c0\u03af\u03c3\u03b7\u03c2 \u03b1\u03c5\u03c4\u03ad\u03c2 \u03c4\u03b9\u03c2 \u03b5\u03bd\u03b1\u03bb\u03bb\u03b1\u03ba\u03c4\u03b9\u03ba\u03ad\u03c2 \u03bb\u03cd\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c4\u03b7\u03bd <a href=\"\/el\/eye-care\/\">\u03a6\u03c1\u03bf\u03bd\u03c4\u03af\u03b4\u03b1 \u039c\u03b1\u03c4\u03b9\u03ce\u03bd<\/a> \u03c0\u03bf\u03b9\u03ba\u03b9\u03bb\u03af\u03b1 \u03bc\u03b1\u03c2:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/el\/xalatan-eye-drop\/\">Xalatan Eye Drop (latanoprost)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/azopt-eye-drops\/\">Azopt Eye Drops (brinzolamide)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/alphagan-p-drop\/\">Alphagan P Drop (brimonidine)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/iotim-eye-drops\/\">Iotim Eye Drops (timolol)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/el\/careprost-eye-drops\/\">Careprost (bimatoprost)<\/a><\/li>\n<\/ul>\n<h3>\u0399\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae \u0391\u03c0\u03bf\u03c0\u03bf\u03af\u03b7\u03c3\u03b7 \u0395\u03c5\u03b8\u03cd\u03bd\u03b7\u03c2<\/h3>\n<p style=\"font-size:13px;color:#555;\">\u039f\u03b9 \u03c0\u03bb\u03b7\u03c1\u03bf\u03c6\u03bf\u03c1\u03af\u03b5\u03c2 \u03c3\u03b5 \u03b1\u03c5\u03c4\u03ae \u03c4\u03b7 \u03c3\u03b5\u03bb\u03af\u03b4\u03b1 \u03c0\u03c1\u03bf\u03bf\u03c1\u03af\u03b6\u03bf\u03bd\u03c4\u03b1\u03b9 \u03bc\u03cc\u03bd\u03bf \u03b3\u03b9\u03b1 \u03b5\u03ba\u03c0\u03b1\u03b9\u03b4\u03b5\u03c5\u03c4\u03b9\u03ba\u03bf\u03cd\u03c2 \u03c3\u03ba\u03bf\u03c0\u03bf\u03cd\u03c2 \u03ba\u03b1\u03b9 \u03b4\u03b5\u03bd \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03bf\u03cd\u03bd \u03c5\u03c0\u03bf\u03ba\u03b1\u03c4\u03ac\u03c3\u03c4\u03b1\u03c4\u03bf \u03b9\u03b1\u03c4\u03c1\u03b9\u03ba\u03ae\u03c2 \u03c3\u03c5\u03bc\u03b2\u03bf\u03c5\u03bb\u03ae\u03c2 \u03b1\u03c0\u03cc \u03ad\u03bd\u03b1\u03bd \u03c0\u03c1\u03bf\u03c3\u03cc\u03bd\u03c4\u03b1 \u03bf\u03c6\u03b8\u03b1\u03bb\u03bc\u03af\u03b1\u03c4\u03c1\u03bf \u03ae \u03bf\u03c0\u03c4\u03bf\u03bc\u03b5\u03c4\u03c1\u03af\u03b1. \u039f\u03b9 \u03c0\u03b1\u03b8\u03ae\u03c3\u03b5\u03b9\u03c2 \u03c4\u03c9\u03bd \u03bc\u03b1\u03c4\u03b9\u03ce\u03bd \u03bc\u03c0\u03bf\u03c1\u03bf\u03cd\u03bd \u03bd\u03b1 \u03b1\u03c0\u03b5\u03b9\u03bb\u03ae\u03c3\u03bf\u03c5\u03bd \u03b3\u03c1\u03ae\u03b3\u03bf\u03c1\u03b1 \u03c4\u03b7\u03bd \u03cc\u03c1\u03b1\u03c3\u03b7 \u2014 \u03b7 \u03be\u03b1\u03c6\u03bd\u03b9\u03ba\u03ae \u03b1\u03c0\u03ce\u03bb\u03b5\u03b9\u03b1 \u03cc\u03c1\u03b1\u03c3\u03b7\u03c2, \u03bf \u03c3\u03bf\u03b2\u03b1\u03c1\u03cc\u03c2 \u03c0\u03cc\u03bd\u03bf\u03c2 \u03ae \u03c4\u03bf \u03c4\u03c1\u03b1\u03cd\u03bc\u03b1 \u03b1\u03c0\u03bf\u03c4\u03b5\u03bb\u03bf\u03cd\u03bd \u03bf\u03c6\u03b8\u03b1\u03bb\u03bc\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae \u03ad\u03ba\u03c4\u03b1\u03ba\u03c4\u03b7 \u03b1\u03bd\u03ac\u03b3\u03ba\u03b7. \u03a3\u03c5\u03bc\u03b2\u03bf\u03c5\u03bb\u03b5\u03c5\u03c4\u03b5\u03af\u03c4\u03b5 \u03c0\u03ac\u03bd\u03c4\u03b1 \u03ad\u03bd\u03b1\u03bd \u03b5\u03c0\u03b1\u03b3\u03b3\u03b5\u03bb\u03bc\u03b1\u03c4\u03af\u03b1 \u03c6\u03c1\u03bf\u03bd\u03c4\u03af\u03b4\u03b1\u03c2 \u03c4\u03c9\u03bd \u03bc\u03b1\u03c4\u03b9\u03ce\u03bd \u03c0\u03c1\u03b9\u03bd \u03be\u03b5\u03ba\u03b9\u03bd\u03ae\u03c3\u03b5\u03c4\u03b5, \u03b4\u03b9\u03b1\u03ba\u03cc\u03c8\u03b5\u03c4\u03b5 \u03ae \u03b1\u03bb\u03bb\u03ac\u03be\u03b5\u03c4\u03b5 \u03bf\u03c0\u03bf\u03b9\u03b1\u03b4\u03ae\u03c0\u03bf\u03c4\u03b5 \u03b8\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1.<\/p>","protected":false},"excerpt":{"rendered":"<p>Alphagan P (brimonidine 0.15%) \u2014 selective alpha-2 agonist eye drop. Three-times-daily IOP control for open-angle glaucoma. Avoid in children under 2 (apnoea risk).<\/p>","protected":false},"featured_media":55868,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3343,3342],"product_tag":[4000,4001],"class_list":{"0":"post-55867","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-eye-care","8":"product_cat-general-health","9":"product_tag-alphagan-p-drop","10":"product_tag-brimonidine","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/55867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=55867"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/55868"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=55867"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=55867"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=55867"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=55867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}